News & Updates

Show Multimedia Only
Pazopanib plus chemo improves response but not survival in advanced ovarian cancer

Pazopanib plus chemo improves response but not survival in advanced ovarian cancer

08 Jun 2023

Treatment with pazopanib combined with chemotherapy leads to better overall response rate (ORR) in patients with recurrent or persistent ovarian cancer but falls short of improving survival, reveals a study. In addition, the combination therapy contributes to an increase in several adverse events (AEs).

08 Jun 2023
Fruit and vegetable intake lowers endometrial cancer risk

Fruit and vegetable intake lowers endometrial cancer risk

02 Jun 2023

Eating fruits and vegetables may help reduce the risk of endometrial cancer, suggests a recent study, noting that specific kinds of fruits and vegetables must be recommended based on their outstanding bioactive components.

02 Jun 2023